IGLL1 Antikörper (N-Term)
Kurzübersicht für IGLL1 Antikörper (N-Term) (ABIN7188601)
Target
Alle IGLL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- IGLL1/IGLC1/IGLC2/IGLC3/IGLC6/IGLC7 Antibody
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the N-terminal region of Human CD179b.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- IGLL1 (Immunoglobulin lambda-Like Polypeptide 1 (IGLL1))
-
Andere Bezeichnung
- IGLL1
-
Hintergrund
- IGLL1, IGL1, Immunoglobulin lambda-like polypeptide 1, CD179 antigen-like family member B, Ig lambda-5, Immunoglobulin omega polypeptide, Immunoglobulin-related protein 14.1, CD antigen CD179b, IGLC1, Ig lambda-1 chain C regions, IGLC2, Ig
-
UniProt
- P15814, P0CG04, P0CG05, P0CG06, P0CF74, A0M8Q6
-
Pathways
- Regulation of Cell Size
Target
-